Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-volume cellular screening for anticancer agents with combinatorial chemical libraries: a new methodology

S E Salmon1, R H Liu-Stevens, Y Zhao

  • 1Arizona Cancer Center, University of Arizona, Tucson 85724, USA.

Molecular Diversity
|October 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dystrophic Scoliosis in Neurofibromatosis and Rib-head Resection: A Case Report.

Malaysian orthopaedic journal·2018
Same author

Intraspinal anomalies in early-onset idiopathic scoliosis.

The bone & joint journal·2017
Same author

Mortality after proximal hip fracture in the Singapore population.

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2017
Same author

The immunopathogenesis of dengue haemorrhagic fever.

Immunology today·2014
Same author

Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.

Cell death & disease·2014
Same author

A novel peptide inhibitor attenuates C-reactive protein's pro-inflammatory effects in-vivo.

International journal of cardiology·2013

A novel assay system enables rapid screening of anticancer drug candidates from large chemical libraries. This method identifies cytotoxic compounds by observing cancer cell lysis around specialized beads, accelerating drug discovery.

Area of Science:

  • Biochemistry
  • Drug Discovery
  • Chemical Biology

Background:

  • Anticancer drug discovery requires efficient screening of large compound libraries.
  • The 'one-bead-one-compound' (OBOC) methodology generates diverse chemical libraries.
  • Existing screening methods can be time-consuming and resource-intensive.

Purpose of the Study:

  • To develop a single-step cytotoxic assay for rapid screening of OBOC libraries.
  • To facilitate the identification of lead anticancer compounds.
  • To enable efficient drug discovery pipelines.

Main Methods:

  • Development of an assay system using OBOC beads with dual, orthogonally cleavable linkers.
  • Incubation of tumor cells with OBOC beads in soft agarose at neutral pH.

Related Experiment Videos

  • Visual identification of cytotoxic compounds based on tumor cell lysis rings.
  • Isolation of active beads for compound structural analysis and resynthesis.

    • Main Results:

    • Successful implementation of a single-step, visual screening assay.
    • Identification of lead cytotoxic compounds from peptidic and non-peptidic libraries.
    • Demonstration of rapid screening capabilities for anticancer drug discovery.

    Conclusions:

    • The developed assay system significantly accelerates the screening of combinatorial libraries.
    • This method provides a robust platform for identifying novel cytotoxic anticancer agents.
    • The OBOC-based assay holds promise for advancing anticancer drug discovery efforts.